Drug intelligence / Profile preview

clotrimazole + hydrocortisone

Development stage
Unknown
Lead developer
AFT Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Candaderm is a topical combination cream containing the broad-spectrum imidazole antifungal clotrimazole (1% w/w) and the mild corticosteroid hydrocortisone (1% w/w). It is developed and marketed by AFT Pharmaceuticals for the short-term treatment of inflamed, itching, and sensitive fungal skin infections, such as tinea (athlete's foot, jock itch, ringworm), fungal skin rash, cutaneous candidiasis (thrush), and fungally infected eczema or dermatitis. Clotrimazole acts by inhibiting fungal ergosterol synthesis, leading to structural and functional impairment of the fungal cytoplasmic membrane. Hydrocortisone provides anti-inflammatory, antipruritic, and vasoconstrictive effects to relieve associated redness, swelling, and itching.

Brand names
CandacortCandadermCanesten HCCanesten Plus
Other names
clotrimazole and hydrocortisoneclotrimazole and hydrocortisone acetateclotrimazole/hydrocortisone
02

Targets

CYP51A1 (Sterol 14α-demethylase)GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on clotrimazole + hydrocortisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clotrimazole + hydrocortisone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call